(New York, NY) – October 9, 2015 – AiCure, a leading artificial intelligence company in healthcare, has been invited to lead a panel discussion at this year’s CNS Summit: Shaping the Future of Drug Development. Adam Hanina, CEO, will be one of several thought leaders participating and driving the discussion around the future development of clinical trials. The initiative, “Clinical Trials of the Future”, brings together experts in clinical trials, technology, and other relevant disciplines to shape the future of how clinical trials are conducted.